|Articles|April 13, 2022
Assessing Multiple CQAs for Monoclonal Antibodies v2
Author(s)Agilent
Automated sample prep and LC–MS peptide mapping approach to characterize and quantify multiple monoclonal antibody (mAb) critical quality attributes (CQAs)
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Top 10 BioPharm International Articles of 2025
2
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
3
Biopharma’s 2025 Transformation: A Recap of Our Top 10 Articles
4
AI, CRISPR, and mRNA Driving Biotech’s Smartest Decade Yet
5